Search

Search Constraints

You searched for: Author/Creator Qu, Sifeng

Search Results

2. Aneustat (OMN54) has aerobic glycolysis‐inhibitory activity and also immunomodulatory activity as indicated by a first‐generation PDX prostate cancer model. Issue 2 (1st March 2018)

5. Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient‐derived, advanced prostate cancer tissue xenograft model. Issue 2 (15th December 2013)